These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 14875527)

  • 21. Histopathologic effects of x-rays, radiophosphorus, nitrogen mustard, urethane, and steroids upon the spleen in leukemias and lymphomas.
    BLOCK M
    Radiology; 1958 Oct; 71(4):477-501. PubMed ID: 13591534
    [No Abstract]   [Full Text] [Related]  

  • 22. COMPARISON OF CYCLOPHOSPHAMIDE (CYTOXAN AND URACIL MUSTARD (U-8344) IN CHRONIC GRANULOCYTIC LEUKEMIA.
    FROMMEYER WB
    Cancer; 1964 Mar; 17():288-96. PubMed ID: 14132176
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical indications for the use of nitrogen mustard and triethylene melamine in malignant lymphomas and leukemias.
    DIAMOND HD
    Ann N Y Acad Sci; 1958 Apr; 68(3):974-8. PubMed ID: 13627744
    [No Abstract]   [Full Text] [Related]  

  • 24. [Panmyelophthisis during the treatment of myelocytic leukemic with urethane].
    ANTIC M
    Vojnosanit Pregl; 1955; 12(5-6):294-8. PubMed ID: 13257043
    [No Abstract]   [Full Text] [Related]  

  • 25. [Observations on the application of CB-1348 in lymphatic leukemias].
    LAWKOWICZ W; BECALSKI J
    Pol Arch Med Wewn; 1959; 29(3):420-2. PubMed ID: 13667708
    [No Abstract]   [Full Text] [Related]  

  • 26. Recent advances in treatment of leukemias and lymphomas.
    IRWIN GE
    W V Med J; 1952 Sep; 48(9):262-4. PubMed ID: 13006097
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of the leukemias and lymphomas; current trends.
    SYKES MP
    J Am Med Womens Assoc; 1952 Sep; 7(9):321-5. PubMed ID: 12990488
    [No Abstract]   [Full Text] [Related]  

  • 28. SYNTHESIS OF N-PHOSPHORYLATED DERIVATIVES OF NITROGEN MUSTARDS WITH LATENT CYTOTOXICITY.
    FRIEDMAN OM; BOGER E; GRUBLIAUSKAS V; SOMMER H
    J Med Chem; 1963 Jan; 6():50-8. PubMed ID: 14174031
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical evaluation of CB 1348 in leukemias and lymphomas.
    DOAN CA; WISEMAN BK; BOURONCLE BA
    Ann N Y Acad Sci; 1958 Apr; 68(3):979-95. PubMed ID: 13627745
    [No Abstract]   [Full Text] [Related]  

  • 30. [Preliminary conclusions in Italy regarding the treatment of various hemopathies with nitrogen mustard compounds and with urethane].
    DI GUGLIELMO G
    Minerva Med; 1949 Sep; 40(44 Pt 2):277-9. PubMed ID: 15392150
    [No Abstract]   [Full Text] [Related]  

  • 31. [Malignant growth and pharmacotherapy].
    von KRESS H
    Arztl Wochensch; 1950 Jun; 5(23):381-4. PubMed ID: 15425420
    [No Abstract]   [Full Text] [Related]  

  • 32. [Casuistics on myleran treatment in chronic myelocytic leukemia].
    KOSENOW W
    Arch Kinderheilkd; 1956; 153(3):251-4. PubMed ID: 13355417
    [No Abstract]   [Full Text] [Related]  

  • 33. [Efficacy and limitations of karyoklastic therapy of leukosis, lymphogranulomatosis, and malignant tumors in childhood].
    WEICKER H
    Kinderarztl Prax; 1950; 18():143-50. PubMed ID: 14785133
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of hematologic neoplasms with nitrogen oxide mustards].
    HORLIN W; SCHMITT W
    Dtsch Med Wochenschr; 1957 Feb; 82(7):247-50. PubMed ID: 13427484
    [No Abstract]   [Full Text] [Related]  

  • 35. A colchicine derivative in therapy of chronic myelocytic leukemia.
    LESSMANN EM; SOKAL JE
    JAMA; 1961 Mar; 175():741-50. PubMed ID: 13761189
    [No Abstract]   [Full Text] [Related]  

  • 36. [Trial therapy of leukoses, lymphogranulomas & malignant tumors with urethane, chloroethylamine & other clinical compounds].
    CHILOV K; IVANOV S; KIRCHEV P
    Izv Meditsinskite Inst Bulg Akad Naukite Sofia Otd Biol Meditsinski Nauki; 1957; 14():73-129. PubMed ID: 13587006
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of malignant lymphogranuloma and chronic leukemia with chloroethylnaphthylamine].
    STORTI E
    Radioter Radiobiol Fis Medica; 1951; 7():156-70. PubMed ID: 14912431
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of 2, 4-diamino-5-p-chlorophenyl-6-ethyl-pirimidine on chronic myelocytic leukemia].
    GIGANTE D; ZOPPINI A
    Gazz Med Ital; 1956 Apr; 115(4):95-9. PubMed ID: 13344889
    [No Abstract]   [Full Text] [Related]  

  • 39. OLD AND NEW DRUGS IN THE CONTROL OF CHRONIC GRANULOCYTIC LEUKEMIA.
    SAMPEY JR
    Am J Pharm Sci Support Public Health; 1964; 136():165-74. PubMed ID: 14203736
    [No Abstract]   [Full Text] [Related]  

  • 40. [Thiouracil therapy of chronic myeloid leukemia].
    Med Hyg (Geneve); 1951 Dec; 9(208):477. PubMed ID: 14899065
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.